Clinical Trial Update: 4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating 4D-150 for neovascular (wet) age-related macular degeneration is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• 4D-150

Snippet

Sponsor: 4D Molecular Therapeutics | Conditions: Neovascular (Wet) Age-Related Macular Degeneration | Phase 1, Phase 2 | Status: RECRUITING